Acyclovir 800mg Tablet
$82.00 – $208.00

| Product name | Lamivudine-Zidovudine-Nevirapine 150mg-300mg-200mg |
|---|---|
| Active Ingredient | Lamivudine-Zidovudine-Nevirapine |
| Dosage | 150mg-300mg-200mg |
| Drug Type | Tablets |
| Indication | HIV Infection |
| Manufacturer | Cipla Limited |
Lamivudine-Zidovudine-Nevirapine 150mg-300mg-200mg Tablets
In stock
Total $206.40
Lamivudine–Zidovudine–Nevirapine tablet is a fixed-dose combination antiviral medicine used to treat HIV (Human Immunodeficiency Virus) infection. It contains three active drugs that work together to control the virus in the body.
This combination helps reduce the amount of HIV in the blood and supports the immune system. It is used as part of antiretroviral therapy (ART) for long-term HIV management.
A qualified specialist such as an infectious disease specialist or HIV treatment expert prescribes this medicine after proper blood tests and clinical evaluation. It is a prescription-only antiviral combination, so it must never be used without medical supervision.
Doctors prescribe this combination when multiple drugs are needed to improve viral control and reduce the risk of resistance.
Lamivudine–Zidovudine–Nevirapine tablet is mainly used for the treatment of HIV infection.
It helps reduce the viral load in the blood, which slows down disease progression and improves immune system strength.
It is used as part of first-line antiretroviral therapy (ART) in many HIV treatment plans, depending on patient condition and doctor choice.
This medicine helps:
control HIV infection in the body
improve immune system function (CD4 count support)
reduce risk of HIV-related complications
support long-term viral suppression
Overall, this combination helps patients manage HIV infection effectively when taken regularly under medical supervision.
This combination works in a three-way antiviral action against HIV.
Lamivudine and Zidovudine block an enzyme called reverse transcriptase. This enzyme is needed for the virus to multiply. When blocked, the virus cannot make new copies.
Nevirapine works by blocking another enzyme called non-nucleoside reverse transcriptase (NNRTI action). It further stops viral replication from continuing.
Together, they:
reduce HIV replication in the body
lower viral load in blood
improve immune response over time
slow down disease progression
In simple words, this medicine does not cure HIV, but it helps control the virus and keeps it at low levels when taken correctly every day.
Lamivudine–Zidovudine–Nevirapine tablet may cause side effects in some patients. Most are mild, but some may need medical attention.
Common side effects include nausea, headache, fatigue, and weakness. These often improve as the body adjusts.
Some patients may experience loss of appetite, dizziness, or stomach discomfort.
A notable effect of this combination is skin rash, especially due to Nevirapine. In some cases, this rash may be mild, but rarely it can become serious.
Less common but serious side effects include:
Doctors usually monitor patients regularly with blood tests and liver function tests during treatment.
If any severe rash, yellowing of skin, or unusual symptoms occur, immediate medical help is required.
Lamivudine–Zidovudine–Nevirapine should always be taken under the supervision of a qualified infectious disease specialist or HIV treatment expert.
Take the medicine exactly as prescribed. Do not skip doses. Missing doses can increase the risk of drug resistance and treatment failure.
Do not stop the medicine suddenly without doctor advice, even if you feel better.
Regular blood tests, liver function tests, and CD4/viral load monitoring are important during treatment.
This medicine may affect the liver, so doctors monitor liver health closely, especially in the first few months.
Avoid alcohol, as it can increase the risk of liver damage and side effects.
Tell your doctor about all other medicines you are taking to avoid drug interactions.
Pregnant and breastfeeding women should use this medicine only if clearly advised by a doctor.
Always take this combination from a trusted pharmacy source to ensure safety and correct strength.
This content is for educational purposes only. Lamivudine–Zidovudine–Nevirapine 150mg–300mg–200mg should be used only under the supervision of a qualified healthcare professional such as an infectious disease specialist or HIV treatment expert, depending on the medical condition being treated.